Global Information
회사소개 | 문의

동물용 백신 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측

Veterinary Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2024

리서치사 Transparency Market Research
발행일 2018년 04월 상품 코드 372780
페이지 정보 영문 188 Pages
가격
US $ 5,795 ₩ 6,541,300 PDF by E-mail (Single user license) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. PDF 인쇄는 가능하지만, 전체 페이지 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 8,795 ₩ 9,927,700 PDF by E-mail (5-user license) help
5명까지 공유하여 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. PDF 전체 페이지 인쇄는 1명당 1회로 한정하며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 11,795 ₩ 13,314,100 PDF by E-mail (Corporate License) help
기업 내 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.


동물용 백신 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측 Veterinary Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2024
발행일 : 2018년 04월 페이지 정보 : 영문 188 Pages

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

한글목차

세계의 동물용 백신(Veterinary Vaccines) 시장에 대해 조사했으며, 시장의 동물별, 기술별, 지역별 매출 예측, 진출 기업 개요 등의 정보를 전해드립니다.

제1장 서론

제2장 가정과 조사 방법

제3장 주요 요약

제4장 시장 개요

  • 제품 개요
  • 주요 업계 이벤트
  • 세계적 유행병
  • 가축에 영향을 미치는 주요 벡터 매개 질환
  • 2010-2014년에 각각의 바이러스 풀을 대표하는 국가
  • 국가별 동물수
  • 규제 시나리오

제5장 시장 동향

  • 시장 성장 촉진요인과 저해요인
  • 성장 촉진요인
  • 성장 저해요인
  • 기회
  • 화이트 스페이스 분석

제6장 기술별 시장 분석

  • 주요 조사 결과
  • 서론
  • 불활성화 백신
  • 약독화 생백신
  • 결합 백신
  • 톡소이드 백신
  • 재조합 백신
  • DNA 백신
  • 주요 동향
  • 기술별 시장 매력도 분석

제7장 동물별 시장 분석

  • 주요 조사 결과
  • 서론
  • 애완동물 시장 가치 점유율 분석
  • 가축 시장 가치 점유율 분석
  • 주요 동향
  • 동물별 시장 매력도 분석

제8장 지역별 시장 분석

  • 북미
  • 유럽
  • 아시아태평양 지역
  • 라틴아메리카
  • 중동 및 아프리카
  • 지역별 시나리오
  • 지역별 시장 매력도 분석

제9장 북미 시장

제10장 유럽 시장

제11장 아시아태평양 지역 시장

제12장 라틴아메리카 시장

제13장 중동 및 아프리카 시장

제14장 경쟁 구도

  • 국가별 시장 점유율 분석
  • 경쟁 매트릭스
  • 기업 개요
    • Bayer AG
    • Bimeda, Inc.
    • Boehringer Ingelheim GmbH
    • Ceva Sante Animale
    • Eli Lilly and Company
    • Merck Animal Health
    • Sanofi S.A.
    • Virbac
    • Zoetis, Inc.

도표

KSM 16.10.26

List of Tables

  • Table 1. Global Veterinary Vaccines Market Size Forecast, by Technology Type, (US$ Mn), 2014-2024
  • Table 2. Global Veterinary Vaccines (companion animals) Market Size Forecast, by Animal Type, (US$ Mn), 2014-2024
  • Table 3. Global Veterinary Vaccines (livestock animals) Market Size Forecast, by Animal Type, (US$ Mn), 2014-2024
  • Table 4. Global Veterinary Vaccines Market Size Forecast, by Region, (US$ Mn), 2014-2024
  • Table 5. North America Veterinary Vaccines Market Size Forecast, by Technology Type, (US$ Mn), 2014-2024
  • Table 6. Global Veterinary Vaccines (companion animals) Forecast, by Animal Type, (US$ Mn), 2014-2024
  • Table 7. Global Veterinary Vaccines (livestock animals) Market Size Forecast, by Animal Type, (US$ Mn), 2014-2024
  • Table 8. North America Veterinary Vaccines Market Size Forecast, by Country, (US$ Mn), 2014-2024
  • Table 9. Europe Veterinary Vaccines Market Size Forecast, by Technology Type, (US$ Mn), 2014-2024
  • Table 10. Europe Veterinary Vaccines (companion animals) Forecast, by Animal Type, (US$ Mn), 2014-2024
  • Table 11. Europe Veterinary Vaccines (livestock animals) Market Size (US$ Mn) Forecast, by Animal Type, (US$ Mn), 2014-2024
  • Table 12. Europe Veterinary Vaccines Market Size Forecast, by Country, (US$ Mn), 2014-2024
  • Table 13. Asia Pacific Veterinary Vaccines Market Size Forecast, by Technology Type, (US$ Mn), 2014-2024
  • Table 14. Asia Pacific Veterinary Vaccines (companion animals) Forecast, by Animal Type, (US$ Mn), 2014-2024
  • Table 15. Asia Pacific Veterinary Vaccines (livestock animals) Market Size Forecast, by Animal Type, (US$ Mn), 2014-2024
  • Table 16. Asia Pacific Veterinary Vaccines Market Size Forecast, by Country, (US$ Mn), 2014-2024
  • Table 17. Latin America Veterinary Vaccines Market Size (US$ Mn) Forecast, by Technology Type, (US$ Mn), 2014-2024
  • Table 18. Latin America Veterinary Vaccines (companion animals) Forecast, by Animal Type, (US$ Mn), 2014-2024
  • Table 19. Latin America Veterinary Vaccines (livestock animals) Market Size (US$ Mn) Forecast, by Animal Type, (US$ Mn), 2014-2024
  • Table 20. Latin America Veterinary Vaccines Market Size Forecast, by Country, (US$ Mn), 2014-2024
  • Table 21. Middle East & Africa Veterinary Vaccines Market Size Forecast, by Technology Type, (US$ Mn), 2014-2024
  • Table 22. Middle East & Africa Veterinary Vaccines (companion animals) Forecast, by Animal Type, (US$ Mn), 2014-2024
  • Table 23. Middle East & Africa Veterinary Vaccines (livestock animals) Market Size (US$ Mn) Forecast, by Animal Type, (US$ Mn), 2014-2024
  • Table 24. Middle East & Africa Veterinary Vaccines Market Size Forecast, by Country, (US$ Mn), 2014-2024

List of Figures

  • FIG. 1. Global Veterinary Vaccines Market Value Share Analysis, by Technology Type, (US$ Mn), 2015 and 2024
  • FIG. 2. Global Inactivated Vaccines Market Revenue, (US$ Mn), 2014-2024
  • FIG. 3. Global Live Attenuated Vaccines Market Revenue, (US$ Mn), 2014-2024
  • FIG. 4. Global Conjugate Vaccines Market Revenue, (US$ Mn), 2014-2024
  • FIG. 5. Global Toxoid Vaccines Market Revenue, (US$ Mn), 2014-2024
  • FIG. 6. Global Recombinant Vaccines Market Revenue, (US$ Mn), 2014-2024
  • FIG. 7. Global DNA Vaccines Market Revenue, (US$ Mn), 2014-2024
  • FIG. 8. Global Veterinary Vaccines (companion animals) Market Value Share Analysis, by Animal Type, (US$ Mn), 2015 and 2024
  • FIG. 9. Global Equine Vaccines Market Revenue, (US$ Mn), 2014-2024
  • FIG. 10. Global Canine Vaccines Market Revenue, (US$ Mn), 2014-2024
  • FIG. 11. Global Feline Vaccines Market Revenue, (US$ Mn), 2014-2024
  • FIG. 12. Global Companion Animal Vaccines Market Revenue, (US$ Mn), 2014-2024
  • FIG. 13. Global Veterinary Vaccines (livestock animals) Market Value Share Analysis, by Animal Type, (US$ Mn), 2015 and 2024
  • FIG. 14. Global Bovine Vaccines Market Revenue, (US$ Mn), 2014-2024
  • FIG. 15. Global Ovine Vaccines Market Revenue, (US$ Mn), 2014-2024
  • FIG. 16. Global Porcine Vaccines Market Revenue, (US$ Mn), 2014-2024
  • FIG. 17. Global Poultry Vaccines Market Revenue, (US$ Mn), 2014-2024
  • FIG. 18. Global Veterinary Vaccines Market Value Share Analysis, by Region, 2015 and 2024
  • FIG. 19. Veterinary Vaccines Market Attractiveness Analysis, by Region, (US$ Mn), 2014-2024
  • FIG. 20. Veterinary Vaccines Market Attractiveness Analysis, by Technology Type, (US$ Mn), 2014-2024
  • FIG. 21. Veterinary Vaccines Market Attractiveness Analysis, by Animal Type, (US$ Mn), 2014-2024
  • FIG. 22. North America Veterinary Vaccines (companion animals) Market Value Share Analysis, by Animal Type, (US$ Mn), 2015 and 2024
  • FIG. 23. North America Veterinary Vaccines (livestock animals) Market Value Share Analysis, by Animal Type, (US$ Mn), 2015 and 2024
  • FIG. 24. North America Veterinary Vaccines (livestock animals) Market Value Share Analysis, by Animal Type, (US$ Mn), 2015 and 2024
  • FIG. 25. North America Market Value Share Analysis, by Country, (US$ Mn), 2015 and 2024
  • U.S. Veterinary Vaccines Market Revenue, (US$ Mn), 2014-2024
  • FIG. 26. U.S. Veterinary Vaccines Market Revenue, (US$ Mn), 2014-2024
  • FIG. 27. Canada Veterinary Vaccines Market Revenue, (US$ Mn), 2014-2024
  • FIG. 28. Europe Veterinary Vaccines Market Value Share Analysis, by Technology Type, (US$ Mn), 2015 and 2024
  • FIG. 29. Europe Veterinary Vaccines (companion animals) Market Value Share Analysis, by Animal Type, (US$ Mn), 2015 and 2024
  • FIG. 30. Europe Veterinary Vaccines (livestock animals) Market Value Share Analysis, by Animal Type, (US$ Mn), 2015 and 2024
  • FIG. 31. Europe Veterinary Vaccines Market Value Share Analysis, by Country, (US$ Mn), 2015 and 2024
  • FIG. 32. Germany Veterinary Vaccines Market Revenue, (US$ Mn), 2014-2024
  • FIG. 33. U.K. Veterinary Vaccines Market Revenue, (US$ Mn), 2014-2024
  • FIG. 34. Asia Pacific Veterinary Vaccines Market Value Share Analysis, by Technology Type, (US$ Mn), 2015 and 2024
  • FIG. 35. Asia Pacific Veterinary Vaccines (companion animals) Market Value Share Analysis, by Animal Type, (US$ Mn), 2015 and 2024
  • FIG. 36. Asia Pacific Veterinary Vaccines (livestock animals) Market Value Share Analysis, by Animal Type, (US$ Mn), 2015 and 2024
  • FIG. 37. Asia Pacific Veterinary Vaccines Market Value Share Analysis, by Country, (US$ Mn) 2015 and 2024
  • FIG. 38. China Veterinary Vaccines Market Revenue, (US$ Mn), 2014-2024
  • FIG. 39. Japan Veterinary Vaccines Market Revenue, (US$ Mn), 2014-2024
  • FIG. 40. Latin America Veterinary Vaccines Market Value Share Analysis, by Technology Type, (US$ Mn), 2015 and 2024
  • FIG. 41. Latin America Veterinary Vaccines (companion animals) Market Value Share Analysis, by Animal Type, (US$ Mn), 2015 and 2024
  • FIG. 42. Latin America Veterinary Vaccines (livestock animals) Market Value Share Analysis, by Animal Type, (US$ Mn), 2015 and 2024
  • FIG. 43. Latin America Market Value Share Analysis, by Country, (US$ Mn), 2015 and 2024
  • FIG. 44. Brazil Veterinary Vaccines Market Revenue, (US$ Mn), 2014-2024
  • FIG. 45. Mexico Veterinary Vaccines Market Revenue, (US$ Mn), 2014-2024
  • FIG. 46. Middle East & Africa Veterinary Vaccines Market Value Share Analysis, by Technology Type, (US$ Mn), 2015 and 2024
  • FIG. 47. Middle East & Africa Veterinary Vaccines (companion animals) Market Value Share Analysis, by Animal Type, (US$ Mn), 2015 and 2024
  • FIG. 48. Middle East & Africa Veterinary Vaccines (livestock animals) Market Value Share Analysis, by Animal Type, (US$ Mn), 2015 and 2024
  • FIG. 49. Saudi Arabia Veterinary Vaccines Market Revenue, (US$ Mn), 2014-2024
  • FIG. 50. Global Veterinary Vaccines Market Share Analysis, by Company (%) (2015)

영문목차

Global Veterinary Vaccines Market: Overview

Transparency Market Research's new report on the global veterinary vaccines market provides detailed insights on the future growth scenario of the said market based on past performance and current scenario. The report offers an exclusive analysis of the global market and also presents insights on key regions and key segments under different category that have been covered in the executive summary section.

The report offers a summary of the global market including a synopsis that highlights the core trends that come to the fore in the market. It also discusses vital indicators such as drivers, challenges, and trends prevalent in the global veterinary vaccines market. The report aspires to serve as a useful guide providing figures related to volume, value, and the development rate of the market from a growth point of view. The report thoroughly looks into each segment and provides estimates based on historic and current values. The evaluation of the veterinary vaccines market presented in the report is in the light of market conditions, including value chain analysis of key technology and animal type under study.

Global Veterinary Vaccines Market: Research Methodology

The making of the report involved an elaborate primary and secondary research phase. The primary research phase involved reaching out to opinion leaders and industry experts via e-mail, face-to-face interviews, and telephonic interviews. Primary interviews were conducted with industry experts on an ongoing basis to endorse data and research analysis. The secondary research phase involved reaching out to accredited industry sources and gathering data.

Global Veterinary Vaccines Market: Competitive Dashboard

The report includes a detailed profile of the key companies currently operating in the veterinary vaccines market. The companies are profiled on the basis of key parameters such as company and financial overview, latest developments, product portfolio, and long-term and short-term growth strategies. The competition matrix covered in the report is likely to assist the existing players to boost their market shares and new entrants in the market to establish a foothold in the veterinary vaccines market.

The report also sheds light on government mandates and regulations pertaining to veterinary vaccines in different countries which is a highlight of the report. The report talks about the manufacturing and sales of veterinary vaccines along with the new research and key development initiatives underway in the global veterinary vaccines market.

Key companies in the veterinary vaccines market, namely Zoetis Inc., Bayer AG, Boehringer Ingelheim GmbH, Merck and Co., Bimeda Inc., Ceva Sante Animale, Sanofi S.A., and Eli Lily and company have been profiled in this report.

What does our report offer?

The report is the outcome of meticulous research work carried out by market analysts employing reliable industry-best analytical tools. The information collated has been validated by seasoned market researchers.

Table of Contents

Chapter 1: Preface

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Objectives
  • 1.4. Key Questions Answered

Chapter 2: Assumptions and Research Methodology

  • 2.1. Report Assumptions
  • 2.2. Acronyms Used
  • 2.3. Research Methodology

Chapter 3: Executive Summary

  • 3.1. Global Veterinary Vaccines Market Snapshot
  • 3.2. Market Opportunity Map

Chapter 4: Market Overview

  • 4.1. Product Overview
  • 4.2. Key Industry Events
  • 4.3. Disease Outbreak Globally: Livestock Animals Disease
  • 4.4. Main (Vector Borne Disease) VBDs affecting livestock
  • 4.5. List of countries representing each virus pool (FMD) for the period 2010-2014
  • 4.6. Animal Population (Mn), by Country in 2015
  • 4.7. Regulatory Scenario

Chapter 5: Market Dynamics

  • 5.1. Drivers and Restraints Snapshot Analysis
  • 5.2. Drivers
  • 5.3. Restraints
  • 5.4. Opportunities
  • 5.5. White Space Analysis

Chapter 6: Veterinary Vaccines Market Analysis, by Technology Type, (US$ Mn) 2014-2024

  • 6.1. Key Findings
  • 6.2. Introduction
  • 6.3. Inactivated Vaccines
  • 6.4. Live Attenuated Vaccines
  • 6.5. Conjugate Vaccines
  • 6.6. Toxoid Vaccines
  • 6.7. Recombinant Vaccines
  • 6.8. DNA Vaccines
  • 6.9. Key Trends
  • 6.10. Veterinary Vaccines Market Attractiveness Analysis, by Technology Type, 2015

Chapter 7: Veterinary Vaccines Market Analysis, by Animal Type, (US$ Mn), 2014-2024

  • 7.1. Key Findings
  • 7.2. Introduction
  • 7.3. Veterinary vaccines (companion animals) Market Value Share Analysis, by Animal Type, (US$ Mn), 2014-2024
    • 7.3.1. Equine
    • 7.3.2. Canine
    • 7.3.3. Feline
  • 7.4. Veterinary vaccines (livestock animals) Market Value Share Analysis, by Animal Type, (US$ Mn), 2014-2024
    • 7.4.1. Bovine
    • 7.4.2. Ovine
    • 7.4.3. Porcine
    • 7.4.4. Poultry
  • 7.5. Key Trends
  • 7.6. Veterinary Vaccines Market Attractiveness Analysis, by Animal Type

Chapter 8: Veterinary Vaccines Market Analysis, by Region, (US$ Mn), 2014-2024

  • 8.1. North America
  • 8.2. Europe
  • 8.3. Asia Pacific
  • 8.4. Latin America
  • 8.5. Middle East & Africa
  • 8.6. Geographical Scenario
  • 8.7. Veterinary Vaccines Market Attractiveness Analysis, by Region, 2015

Chapter 9: North America Veterinary Vaccines Market Analysis, (US$ Mn), 2014-2024

  • 9.1. North America Veterinary Vaccines Market Value Share Analysis, by Technology Type, (US$ Mn), 2014-2024
    • 9.1.1. Inactivated Vaccines
    • 9.1.2. Conjugate Vaccines
    • 9.1.3. Live Attenuated Vaccines
    • 9.1.4. Toxoid Vaccines
    • 9.1.5. Other Vaccines
  • 9.2. North America Veterinary Vaccines Market Value Share Analysis, by Animal Type, (US$ Mn), 2014-2024
    • 9.2.1. Animal Type
      • 9.2.1.1. Companion Animals
        • 9.2.1.1.1. Equine
        • 9.2.1.1.2. Canine
        • 9.2.1.1.3. Feline
      • 9.2.1.2. Livestock Animals
        • 9.2.1.2.1. Bovine
        • 9.2.1.2.2. Ovine
        • 9.2.1.2.3. Porcine
        • 9.2.1.2.4. Poultry
        • 9.2.1.2.5. Others
  • 9.3. U.S. Veterinary Vaccines Market Analysis, (US$ Mn), 2014-2024
  • 9.4. Canada Veterinary Vaccines Market Analysis, (US$ Mn), 2014-2024

Chapter 10: Europe Veterinary vaccines Market Revenue Analysis, (US$ Mn), 2014-2024

  • 10.1. Europe Veterinary Vaccines Market Value Share Analysis, by Technology Type, (US$ Mn), 2014-2024
    • 10.1.1. Inactivated Vaccines
    • 10.1.2. Conjugate Vaccines
    • 10.1.3. Live Attenuated Vaccines
    • 10.1.4. Toxoid Vaccines
    • 10.1.5. Other Vaccines
  • 10.2. Europe Veterinary Vaccines Market Value Share Analysis, by Animal Type, (US$ Mn), 2014-2024
    • 10.2.1. Animal Type
      • 10.2.1.1. Companion Animals
        • 10.2.1.1.1. Equine
        • 10.2.1.1.2. Canine
        • 10.2.1.1.3. Feline
      • 10.2.1.2. Livestock Animals
        • 10.2.1.2.1. Bovine
        • 10.2.1.2.2. Ovine
        • 10.2.1.2.3. Porcine
        • 10.2.1.2.4. Poultry
        • 10.2.1.2.5. Others
  • 10.3. Europe Veterinary Vaccines Market Value Share Analysis, by Country, (US$ Mn), 2014-2024
  • 10.4. Germany Veterinary Vaccines Market Analysis, (US$ Mn), 2014-2024
  • 10.5. U.K. Veterinary Vaccines Market Analysis, (US$ Mn), 2014-2024

Chapter 11: Asia Pacific Veterinary Vaccines Market Analysis, (US$ Mn), 2014-2024

  • 11.1. Asia Pacific Veterinary Vaccines Market Value Share Analysis, by Technology Type, (US$ Mn), 2014-2024
    • 11.1.1. Inactivated Vaccines
    • 11.1.2. Conjugate Vaccines
    • 11.1.3. Live Attenuated Vaccines
    • 11.1.4. Toxoid Vaccines
    • 11.1.5. Other Vaccines
  • 11.2. Asia Pacific Veterinary Vaccines Market Value Share Analysis, by Animal Type, (US$ Mn), 2014-2024
    • 11.2.1. Animal Type
      • 11.2.1.1. Companion Animals
        • 11.2.1.1.1. Equine
        • 11.2.1.1.2. Canine
        • 11.2.1.1.3. Feline
      • 11.2.1.2. Livestock Animals
        • 11.2.1.2.1. Bovine
        • 11.2.1.2.2. Ovine
        • 11.2.1.2.3. Porcine
        • 11.2.1.2.4. Poultry
        • 11.2.1.2.5. Others
  • 11.3. Asia Pacific Veterinary Vaccines Market Value Share Analysis, by Country, (US$ Mn), 2014-2024
  • 11.4. China Veterinary Vaccines Market Analysis, (US$ Mn), 2014-2024
  • 11.5. Japan Veterinary Vaccines Market Analysis, (US$ Mn), 2014-2024

Chapter 12: Latin America Veterinary vaccines Market Revenue Analysis, (US$ Mn), 2014-2024

  • 12.1. Latin America Veterinary Vaccines Market Value Share Analysis, by Technology Type, (US$ Mn), 2014-2024
    • 12.1.1. Inactivated Vaccines
    • 12.1.2. Conjugate Vaccines
    • 12.1.3. Live Attenuated Vaccines
    • 12.1.4. Toxoid Vaccines
    • 12.1.5. Other Vaccines
  • 12.2. Latin America Veterinary Vaccines Market Value Share Analysis, by Animal Type, (US$ Mn), 2014-2024
    • 12.2.1. Animal Type
      • 12.2.1.1. Companion Animals
        • 12.2.1.1.1. Equine
        • 12.2.1.1.2. Canine
        • 12.2.1.1.3. Feline
      • 12.2.1.2. Livestock Animals
        • 12.2.1.2.1. Bovine
        • 12.2.1.2.2. Ovine
        • 12.2.1.2.3. Porcine
        • 12.2.1.2.4. Poultry
        • 12.2.1.2.5. Others
  • 12.3. Latin America Veterinary Vaccines Market Value Share Analysis, by Country, (US$ Mn), 2014-2024
  • 12.4. Brazil Veterinary Vaccines Market Analysis, (US$ Mn), 2014-2024
  • 12.5. Mexico Veterinary Vaccines Market Analysis, (US$ Mn), 2014-2024

Chapter 13: Middle East & Africa Veterinary Vaccines Market Revenue Analysis, (US$ Mn), 2014-2024

  • 13.1. Middle East & Africa Veterinary Vaccines Market Value Share Analysis, by Technology Type, (US$ Mn), 2014-2024
    • 13.1.1. Inactivated Vaccines
    • 13.1.2. Conjugate Vaccines
    • 13.1.3. Live Attenuated Vaccines
    • 13.1.4. Toxoid Vaccines
    • 13.1.5. Other Vaccines
  • 13.2. Middle East & Africa Veterinary Vaccines Market Value Share Analysis, by Animal Type, (US$ Mn), 2014-2024
    • 13.2.1. Animal Type
      • 13.2.1.1. Companion Animals
        • 13.2.1.1.1. Equine
        • 13.2.1.1.2. Canine
        • 13.2.1.1.3. Feline
      • 13.2.1.2. Livestock Animals
        • 13.2.1.2.1. Bovine
        • 13.2.1.2.2. Ovine
        • 13.2.1.2.3. Porcine
        • 13.2.1.2.4. Poultry
        • 13.2.1.2.5. Others
  • 13.3. Middle East & Africa Veterinary Vaccines Market Value Share Analysis, by Country, (US$ Mn), 2014-2024
  • 13.4. Saudi Arabia Veterinary Vaccines Market Analysis, (US$ Mn), 2014-2024

Chapter 14: Competitive Landscape

  • 14.1. Veterinary Vaccine Market Share Analysis, by Company, (2015)
  • 14.2. Competition Matrix
    • 14.2.1. Bayer AG
    • 14.2.2. Bimeda, Inc.
    • 14.2.3. Boehringer Ingelheim GmbH
    • 14.2.4. Ceva Sante Animale
    • 14.2.5. Eli Lilly and Company (Elanco Animal Health)
    • 14.2.6. Merck Animal Health
    • 14.2.7. Sanofi S.A. (Merial Animal Health)
    • 14.2.8. Virbac
    • 14.2.9. Zoetis, Inc.
  • 14.3. Company Profiles
    • 14.3.1. Bayer AG
      • 14.3.1.1. Company Details
      • 14.3.1.2. Company Description
      • 14.3.1.3. Business Overview
      • 14.3.1.4. SWOT Analysis
      • 14.3.1.5. Financials
      • 14.3.1.6. Strategic Overview
      • 14.3.1.7. Product Portfolio
      • 14.3.1.8. Recent Developments
    • 14.3.2. Bimeda, Inc.
      • 14.3.2.1. Company Details
      • 14.3.2.2. Company Description
      • 14.3.2.3. Business Overview
      • 14.3.2.4. SWOT Analysis
      • 14.3.2.5. Financials
      • 14.3.2.6. Strategic Overview
      • 14.3.2.7. Product Portfolio
      • 14.3.2.8. Recent Developments
    • 14.3.3. Boehringer Ingelheim GmbH
      • 14.3.3.1. Company Details
      • 14.3.3.2. Company Description
      • 14.3.3.3. Business Overview
      • 14.3.3.4. SWOT Analysis
      • 14.3.3.5. Financials
      • 14.3.3.6. Strategic Overview
      • 14.3.3.7. Product Portfolio
      • 14.3.3.8. Recent Developments
    • 14.3.4. Ceva Sante Animale
      • 14.3.4.1. Company Details
      • 14.3.4.2. Company Description
      • 14.3.4.3. Business Overview
      • 14.3.4.4. SWOT Analysis
      • 14.3.4.5. Financials
      • 14.3.4.6. Strategic Overview
      • 14.3.4.7. Product Portfolio
      • 14.3.4.8. Recent Developments
    • 14.3.5. Eli Lilly and Company (Elanco Animal Health)
      • 14.3.5.1. Company Details
      • 14.3.5.2. Company Description
      • 14.3.5.3. Business Overview
      • 14.3.5.4. SWOT Analysis
      • 14.3.5.5. Financials
      • 14.3.5.6. Strategic Overview
      • 14.3.5.7. Product Portfolio
      • 14.3.5.8. Recent Developments
    • 14.3.6. Merck Animal Health
      • 14.3.6.1. Company Details
      • 14.3.6.2. Company Description
      • 14.3.6.3. Business Overview
      • 14.3.6.4. SWOT Analysis
      • 14.3.6.5. Financials
      • 14.3.6.6. Strategic Overview
      • 14.3.6.7. Product Portfolio
      • 14.3.6.8. Recent Developments
    • 14.3.7. Sanofi S.A. (Merial Animal Health)
      • 14.3.7.1. Company Details
      • 14.3.7.2. Company Description
      • 14.3.7.3. Business Overview
      • 14.3.7.4. SWOT Analysis
      • 14.3.7.5. Financials
      • 14.3.7.6. Strategic Overview
      • 14.3.7.7. Product Portfolio
      • 14.3.7.8. Recent Developments
    • 14.3.8. Virbac
      • 14.3.8.1. Company Details
      • 14.3.8.2. Company Description
      • 14.3.8.3. Business Overview
      • 14.3.8.4. SWOT Analysis
      • 14.3.8.5. Financials
      • 14.3.8.6. Strategic Overview
      • 14.3.8.7. Product Portfolio
      • 14.3.8.8. Recent Developments
    • 14.3.9. Zoetis, Inc.
      • 14.3.9.1. Company Details
      • 14.3.9.2. Company Description
      • 14.3.9.3. Business Overview
      • 14.3.9.4. SWOT Analysis
      • 14.3.9.5. Financials
      • 14.3.9.6. Strategic Overview
      • 14.3.9.7. Product Portfolio
      • 14.3.9.8. Recent Developments
Back to Top
아시아 최대 시장정보 제공
전세계에서 발행되고 있는 모든 시장조사보고서를
다루고 있습니다.
사이트에서 검색되지 않는 보고서도 문의 바랍니다.
 
BCC Research